Influence on clinical biochemistry values of black-tufted marmosets (Callithrix penicillata) anesthetized with isoflurane or sevoflurane

ABSTRACT The objective of this study was to evaluate the clinical biochemistry behavior of Black-Tufted Marmosets (Callithrix penicillatta) submitted to blood collection without sedation and after general anesthesia with anesthetics isoflurane or sevoflurane. Blood collections were performed on (M1) day before anesthesia by physical restraint, and (M2) after anesthesia. There were four groups: Isoflurane (GI) and Sevoflurane (GS) using an anesthetic box. GIM: isoflurane induction with mask for a shorter period. Control group (GP): physical restraint in both moments. Plasma was separated and frozen to measure clinic biochemistry values. Urea was higher at M2 in groups GI and GP. AST was higher in M2 in GI, GS, and GP and only GI showed an increase in CK in M2. Glucose was higher in M1 in the GI, GS, and GP groups and fructosamine was higher in M2 in the GI. Stress caused by physical restraint can cause biochemical changes and these must be considered when interpreting the exams. Both the inhalational anesthetic isoflurane and sevoflurane did not cause clinically significant changes in clinical biochemistry results

Interaction of Genetic Variations in NFE2L2 and SELENOS Modulates the Risk of Hashimoto's Thyroiditis.

Background: Several single-nucleotide polymorphisms (SNPs) are known to increase the risk of Hashimoto's thyroiditis (HT); such SNPs reside in thyroid-specific genes or in genes related to autoimmunity, inflammation, and/or cellular defense to stress. The transcription factor Nrf2, encoded by NFE2L2, is a master regulator of the cellular antioxidant response. This study aimed to evaluate the impact of genetic variation in NFE2L2 on the risk of developing HT. Methods: In a case-control candidate gene association study, functional SNPs in the NFE2L2 promoter (rs35652124, rs6706649, and rs6721961) were examined either as independent risk factors or in combination with a previously characterized HT risk allele (rs28665122) in the gene SELENOS, encoding selenoprotein S (SelS). A total of 997 individuals from the north of Portugal (Porto) were enrolled, comprising 481 HT patients and 516 unrelated healthy controls. SELENOS and NFE2L2 SNPs were genotyped using TaqMan <sup>®</sup> assays and Sanger sequencing, respectively. Odds ratios (ORs) were calculated using logistic regression, with adjustment for sex and age. Expression of SelS was analyzed by immunohistochemistry in thyroid tissue from HT patients and control subjects. Molecular interactions between the Nrf2 and SelS pathways were investigated in thyroid tissues from mice and in rat PCCL3 thyroid follicular cells. Results: When all three NFE2L2 SNPs were considered together, the presence of one or more minor alleles was associated with a near-significant increased risk (OR = 1.43, p = 0.072). Among subjects harboring only major NFE2L2 alleles, there was no increased HT risk associated with heterozygosity or homozygosity for the SELENOS minor allele. Conversely, in subjects heterozygous or homozygous for the SELENOS risk allele, the presence of an NFE2L2 minor allele significantly increased HT risk by 2.8-fold (p = 0.003). Immunohistochemistry showed reduced expression of SelS in thyroid follicular cells of HT patients. In Nrf2 knockout mice, there was reduced expression of SelS in thyroid follicular cells; conversely, in PCCL3 cells, reducing SelS expression caused reduced activity of Nrf2 signaling. Conclusions: The NFE2L2 promoter genotype interacts with the SELENOS promoter genotype to modulate the risk of HT in a Portuguese population. This interaction may be due to a bidirectional positive feedback between the Nrf2 and SelS pathways

Removing Discrete Ambiguities in CP Asymmetry Measurements

We discuss methods to resolve the ambiguities in CP violating phase angles $\phi$ that are left when a measurement of $\sin 2 \phi$ is made. We show what knowledge of hadronic quantities will be needed to fully resolve all such ambiguities.Comment: 23 pages, revtex, no figure

Proteção do cafeeiro contra cercosporiose por acibenzolar-S-metil e proteína harpina

O objetivo deste trabalho foi avaliar, em cafeeiro suscetível, a proteção contra a cercosporiose, pela aplicação da proteína harpina e acibenzolar-S-metil (ASM), e avaliar seu efeito na germinação de conídios e crescimento micelial in vitro. No primeiro experimento, cafeeiros tratados com ASM (25, 50, 100, 200 μg mL-1) receberam o inóculo de uma suspensão de conídios de Cercospora coffeicola, e a severidade da doença foi avaliada aos 30 e 60 dias após a inoculação. No segundo experimento, cafeeiros foram aspergidos com harpina (7,5, 15, 30, 60, 120 μg mL-1), tendo-se utilizado o mesmo procedimento. No terceiro experimento, plantas aspergidas previamente com ASM (200 μg mL-1) ou harpina (15 μg mL-1) foram tratadas novamente com esses produtos, aos 30 dias após terem recebido inóculo do patógeno. ASM e harpina protegeram os cafeeiros contra cercosporiose 30 dias após a inoculação com C. coffeicola. Entretanto, 60 dias após a inoculação, apenas o ASM (200 μg mL-1), com uma ou duas aplicações, protegeu as plantas contra C. coffeicola. Os cafeeiros foram protegidos contra cercosporiose, em reaplicação de harpina, 30 dias após o primeiro tratamento com essa proteína. Harpina e acibenzolar-S-metil não inibiram o desenvolvimento micelial nem a germinação in vitro dos conídios do patógeno